share_log

Earnings Beat: Bath & Body Works, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Earnings Beat: Bath & Body Works, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

盈利快報:Bath & Body Works, Inc.剛剛超過了分析師的預期,分析師一直在更新他們的模型
Simply Wall St ·  03/03 08:28

Shareholders might have noticed that Bath & Body Works, Inc. (NYSE:BBWI) filed its full-year result this time last week. The early response was not positive, with shares down 3.3% to US$45.68 in the past week. It looks like a credible result overall - although revenues of US$7.4b were what the analysts expected, Bath & Body Works surprised by delivering a (statutory) profit of US$3.84 per share, an impressive 24% above what was forecast. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

股東們可能已經注意到,Bath & Body Works, Inc.(紐約證券交易所代碼:BBWI)上週這個時候公佈了全年業績。早期的反應並不樂觀,過去一週股價下跌3.3%,至45.68美元。總體而言,這似乎是一個可信的業績——儘管分析師預期的收入爲74億美元,但Bath & Body Works出人意料地實現了每股3.84美元的(法定)利潤,比預期高出24%。根據結果,分析師更新了他們的盈利模式,很高興知道他們是否認爲公司的前景發生了巨大變化,或者業務是否照舊。考慮到這一點,我們收集了最新的法定預測,以了解分析師對明年的預期。

earnings-and-revenue-growth
NYSE:BBWI Earnings and Revenue Growth March 3rd 2024
紐約證券交易所:BBWI 收益和收入增長 2024 年 3 月 3 日

Taking into account the latest results, Bath & Body Works' 19 analysts currently expect revenues in 2025 to be US$7.42b, approximately in line with the last 12 months. Statutory earnings per share are forecast to sink 15% to US$3.32 in the same period. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$7.44b and earnings per share (EPS) of US$3.39 in 2025. The analysts seem to have become a little more negative on the business after the latest results, given the small dip in their earnings per share numbers for next year.

考慮到最新業績,Bath & Body Works的19位分析師目前預計,2025年的收入將達到74.2億美元,與過去12個月大致持平。預計同期每股法定收益將下降15%,至3.32美元。然而,在最新業績公佈之前,分析師曾預計2025年收入爲74.4億美元,每股收益(EPS)爲3.39美元。鑑於明年每股收益略有下降,分析師在最新業績公佈後似乎對該業務變得更加消極了。

Despite cutting their earnings forecasts,the analysts have lifted their price target 8.7% to US$50.43, suggesting that these impacts are not expected to weigh on the stock's value in the long term. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Bath & Body Works, with the most bullish analyst valuing it at US$78.00 and the most bearish at US$40.00 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

儘管下調了收益預期,但分析師仍將目標股價上調了8.7%,至50.43美元,這表明從長遠來看,這些影響預計不會打壓該股的價值。研究分析師的估計範圍,評估異常值與平均值的差異程度也可能很有啓發性。對Bath & Body Works的看法有所不同,最看漲的分析師將其估值爲78.00美元,最看跌的爲每股40.00美元。注意到分析師目標股價的巨大差距了嗎?對我們來說,這意味着基礎業務存在相當廣泛的可能情景。

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We would also point out that the forecast 0.2% annualised revenue decline to the end of 2025 is better than the historical trend, which saw revenues shrink 12% annually over the past five years By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 5.2% per year. So while a broad number of companies are forecast to grow, unfortunately Bath & Body Works is expected to see its revenue affected worse than other companies in the industry.

從現在的大局來看,我們可以理解這些預測的方法之一是看看它們如何與過去的業績和行業增長預期相比較。我們還要指出,到2025年底,預計年化收入下降0.2%,好於歷史趨勢,在過去五年中,收入每年下降12%。相比之下,我們的數據表明,類似行業的其他公司(有分析師的報道)的收入預計將每年增長5.2%。因此,儘管預計將有許多公司增長,但不幸的是,預計Bath & Body Works的收入將比業內其他公司受到的影響更嚴重。

The Bottom Line

底線

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Bath & Body Works. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Bath & Body Works' revenue is expected to perform worse than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.

最大的擔憂是,分析師下調了每股收益預期,這表明Bath & Body Works可能會面臨業務不利因素。幸運的是,分析師還重申了他們的收入預期,表明收入符合預期。儘管我們的數據確實表明,預計Bath & Body Works的收入表現將低於整個行業。我們注意到目標股價已上調,這表明分析師認爲該業務的內在價值可能會隨着時間的推移而提高。

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Bath & Body Works going out to 2027, and you can see them free on our platform here.

考慮到這一點,我們仍然認爲該業務的長期發展軌跡對於投資者來說更爲重要。我們對Bath & Body Works的預測將持續到2027年,你可以在我們的平台上免費查看。

Don't forget that there may still be risks. For instance, we've identified 3 warning signs for Bath & Body Works (1 can't be ignored) you should be aware of.

別忘了可能仍然存在風險。例如,我們已經確定了 Bath & Body Works 的 3 個警告標誌(1 個不容忽視),你應該注意。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論